The Shotlee Journal
Browse Shotlee articles about Weight Loss.
Showing 9 / 1250 Weight Loss articles
Abbott is now marketing Extensior, a second brand of Novo Nordisk's Ozempic, for type 2 diabetes management in India. This partnership comes as the semaglutide patent nears expiry, potentially lowering prices. With proven benefits in HbA1c control, weight loss, and cardiovascular risk reduction, it expands access in a country with over 100 million diabetes cases.
With nearly 100 million Indians overweight or obese, Eli Lilly is ramping up access to its game-changing drug Mounjaro across the country. President Winslow Tucker emphasizes responsible use under medical supervision amid rising demand for GLP-1 therapies. This move signals a shift in tackling obesity as a serious disease linked to heart complications.
Following up on real mom experiences with GLP-1 medications, dietician Diana Reid reveals the hidden pitfalls beyond the 'magic wand' hype. From the beach ball metaphor for body set points to essential protein and strength training, learn how to support your body properly. This balanced guide covers benefits like reduced food noise and risks like hair thinning for informed decisions.
Ozempic and metformin are both widely used for Type 2 diabetes management, sharing benefits like blood sugar control and potential weight loss effects, but recent side effect warnings highlight their overlaps and differences. While metformin serves 120 million people worldwide as a daily tablet, Ozempic is a weekly injection for adults. Understand why consulting your doctor is essential before switching.
Novo Nordisk's stock has erased the last of its Wegovy-driven gains in a brutal week, down 21% after next-gen obesity drug CagriSema underperformed rivals. Despite 20.2% weight loss in trials, analysts downgrade amid patent cliffs and competition from Eli Lilly's tirzepatide. The company's pivot to oral Wegovy offers hope, but diversification pressures mount.
The UK's MHRA has issued a critical warning about counterfeit Mounjaro pens following reports from Eli Lilly. These fake pens contain tirzepatide but may not be sterile, posing potential health risks. Patients are urged to verify batch numbers and report suspicions to the Yellow Card scheme.
In eastern Denmark, Ellegaard Gottingen Minipigs A/S breeds specialized $3,000 minipigs vital to Europe's drug pipeline, including Novo Nordisk's Ozempic and Wegovy. These biosecure facilities address supply chain vulnerabilities exposed by the pandemic's monkey shortages. As the EU pushes for biotech independence, these smaller, human-like pigs offer a strategic alternative.
Just as smartphones propelled Ireland's economy post-financial crisis, GLP-1 weight-loss drugs like Eli Lilly's Mounjaro and Zepbound are set to do the same. With factories in Kinsale and Limerick producing key ingredients, Ireland eyes massive tax windfalls and export spikes. Gallup data shows US obesity falling to 37%, crediting these therapies.
As the Ozempic generation ramps up protein intake to support weight loss, Minneapolis-based Puris Proteins has surged to $200 million in revenue as America's top pea protein maker. From basement soybean breeding to supplying giants like Cargill, this family business is powering nutritious habits for GLP-1 users. Here's the story behind their explosive growth.
